Contagion Editorial Staff

While more information on the Zika virus is revealed, researchers are saying that the United States can rest a little easier over concerns of a large-scale outbreak.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, discusses routine testing for Powassan virus.

A new study has revealed more information on how microbes confer resistance to antibiotics.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses efforts to understand the Zika virus.

A review of the top two video interviews from 2016 is included here.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, discusses the treatment of Powassan virus.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses Zika response at NYU Langone Medical Center.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, discusses the differential diagnosis of Powassan virus.

A new study reveals evidence that a longer course of antibiotics is more effective for treating ear infections in young children.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses Zika virus diagnostics.

Although herpes remains one of the most prevalent sexually transmitted infections in the United States, the US Preventive Services Task Force is calling for less routine testing.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, explains why it is important for healthcare practitioners to be aware of Powassan virus.

Americans are gearing up for travel to celebrate the winter holidays amid a mild start to the influenza season.

Researchers recently utilized Twitter user data to discern public opinions on the human papilloma virus (HPV) vaccine, with surprising results.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, explains how hospitals and healthcare systems can identify where resources need to be allocated when preparing for Zika outbreaks.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, talks about prevalence of Zika in pregnant women in New York.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, discusses the prevalence of Powassan virus in humans in the United States.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses the value his research team’s findings will bring to healthcare practitioners.

Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, discusses how Infectious Disease specialists, pharmacists, and nurses can work together on antimicrobial stewardship.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses the clinical significance of his studies regarding the national prevalence of multidrug-resistant organisms.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses push and pull incentives that drive antibiotic development.

Researchers at the Mailman School of Public Health at Columbia University are the first to develop a computer model that predicts influenza activity down to the local level.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses the results of his research into the national prevalence of multidrug-resistant organisms.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses global and national initiatives for the development of new antibiotics.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, explains the economics of antimicrobial development.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, examines the threat that antibiotic resistance poses to modern medicine.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses the economic opportunities driving the development of new pharmaceuticals.

Following best practices for the “placement, maintenance, and removal” of catheters is just as important as appropriate testing in order to reduce catheter-associated urinary tract infections (CAUTIs).

Barry Kreiswirth, PhD, founding director, Public Health Research Institute Tuberculosis Center, professor of medicine at Rutgers University, examines the difficulty of developing new, effective antibiotics as more and more bacteria continue to develop resistance.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how antibiotic stewardship programs are impacting antibiotic resistance.